Click to Share
 

Ataxia Press Releases

Exclusive News
Topics Locations Industries Dates

By NEUROLIXIS
A research team specialized in the study of nervous system disorders has found that NLX-112, a serotonin 5-HT1A receptor agonist developed by Neurolixis, reversed motor deficits in a transgenic model of Spinocerebellar ataxia3 (SCA3), a rare genetic...

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share